Global Cell Culture Media Market

Cell Culture Media Market Size, Share, Growth Analysis, By Type(Serum-Free Media (CHO Media, HEK 293 Media, BHK Media, VERO Cell Media), By Application(Biopharmaceutical Production (Monoclonal Antibody Production, Vaccine Production, Other Therapeutic Protein Production Applications), Diagnostics), By End User(Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2057 | Region: Global | Published Date: September, 2024
Pages: 213 | Tables: 168 | Figures: 79

Cell Culture Media Market Regional Insights

North America retains the largest market share due to factors such as the presence of key manufacturers, a high prevalence of diseases which is creating significant demand for drugs and other medications, advancements in technologies found in the preclinical and clinical segment, the rise in health awareness among the population and high disposable income. According to The American Cancer Society, Inc., in 2020, approximately 1.9 million new cancer cases were diagnosed in the U.S. and approximately 609,360 deaths occurred. Factors such as this will increase the demand and growth of the market during the forecast period.  

Asia-Pacific is expected to register the highest CAGR over the forecast period. The increased demand for life science research and swift development of biopharmaceuticals, oncology, and stem cell research are a few key factors to boost the market in this region. In the addition, increasing initiatives by key companies to cater to the swiftly elevating commercialization of high-quality culture media for various pharmaceutical and biotechnological processes as per the customer needs is another key factor contributing to the growth of the cell culture media market in Asia Pacific. Demand in Asia Pacific is anticipated to grow at a significant rate due to numerous regional research organizations, low manufacturing costs, low labor costs, improved healthcare infrastructure, and increasing investment by the American and European market giants in Asian countries such as China, and India driving the demand for the cell culture media in the Asia-Pacific region.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Culture Media Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.23 billion in 2023 to USD 20.45 billion by 2031, growing at a CAGR of 16.02% during the forecast period (2024-2031).

The cell culture media market is highly consolidated, with the dominant share belonging to major players. In 2023, ThermoFisher Scientific and Danaher together accounted for the major cell culture media market share. The leading positions of these companies are due to the strong distribution network and their constant work on launching new products in to the market. In addition, such strategic decisions as mergers, acquisitions, or expansion of manufacturing sites also lead these players to more solid positions on the market. 'Thermo Fisher Scientific ', 'Merck KGAA ', 'Danaher ', 'Sartorius AG ', 'Corning Incorporated ', 'Fujifilm Holdings Corporation ', 'Lonza ', 'Becton, Dickinson and Company (BD) ', 'Stemcell Technologies ', 'Miltenyi Biotec ', 'Himedia Laboratories ', 'Biologos ', 'PromoCell GmbH ', 'InvivoGen ', 'Pan-Biotech ', 'Cellular Technology Limited ', 'Cyagen Biosciences ', 'Biowest ', 'Akron Biotech ', 'Kcell Biosciences'

Researchers across the globe have been engaged in innovative work aimed at developing new techniques to maximize the efficiency of cell culture media for diverse clinical applications. Observations have shown albumins to be integral during the manufacturing of life-saving monoclonal antibodies and recombinant proteins. Albumin binds and stabilizes an array of critical small molecules and ions, lending stability. Therefore, augmenting culture mediums with recombinant mammalian albumin supplements is anticipated to considerably spur market growth and boost product yields. It is projected that embracing these advanced technologies will further accelerate the expansion of the market throughout the projected period. 

Increasing Acceptance for Gene Therapies: Gene therapy is applied for treating diverse acquired and inherited neurological diseases. Moreover, gene products are mentioned to lessen cellular dysfunction and have been validated as a novel therapeutic approach. In addition, several applications in gene therapy have emerged at the moment, while scientists globally are involved in R&D to uncover novel applications. This is expected to boost the demand for cell culture media. 

North America retains the largest market share due to factors such as the presence of key manufacturers, a high prevalence of diseases which is creating significant demand for drugs and other medications, advancements in technologies found in the preclinical and clinical segment, the rise in health awareness among the population and high disposable income. According to The American Cancer Society, Inc., in 2020, approximately 1.9 million new cancer cases were diagnosed in the U.S. and approximately 609,360 deaths occurred. Factors such as this will increase the demand and growth of the market during the forecast period.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell Culture Media Market

Report ID: SQMIG35H2057

$5,300
BUY NOW GET FREE SAMPLE